Oral Sirolimus Appears to Augment Efficacy of BMS TCTMD Short-term use of oral sirolimus after bare-metal stent (BMS) implantation reduces restenosis and repeat revascularization compared with stenting alone and may potentially match the efficacy of drug-eluting stents (DES) at lower cost. The findings ... |
